Puma Bio commercial chief to depart October 18

• Puma Biotechnology (NASDAQ:PBYI) discloses that Chief Commercial Officer Steven Lo will resign effective Friday, October 18, to accept the CEO job at another biotech.
• A search for a successor has been initiated.
• Shares down 10% premarket on modest volume.